AI-assisted, human-published
06/03/2025 /Funding Events
Antheia Secures $56 Million to Revolutionize Pharmaceutical Supply Chains
Antheia secures Series C financing to expand commercialization of biosynthetic pharmaceutical ingredients, address critical bottlenecks in global pharmaceutical supply chains, and revolutionize pharmaceutical manufacturing.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com